Potential Issues with Naltrexone Use
Naltrexone can cause serious hepatotoxicity, precipitate severe opioid withdrawal, and has multiple common side effects including nausea, headache, and psychiatric symptoms that require careful monitoring. 1
Hepatotoxicity Concerns
Naltrexone carries a risk of hepatotoxicity, particularly at higher doses:
- At standard doses (50mg daily oral), hepatotoxicity is uncommon in patients with normal liver function 1
- Higher doses (up to 300mg daily) have been shown to cause hepatocellular injury in a substantial proportion of patients 1
- Transient, asymptomatic hepatic transaminase elevations have been observed in clinical trials 1
- Patients should be monitored for symptoms of acute hepatitis and discontinue naltrexone if these develop 1
Despite these warnings, several studies have shown that:
- Naltrexone does not significantly alter liver function at therapeutic doses in patients without pre-existing liver disease 2, 3
- Even high-dose naltrexone (200mg bid) has been used without adverse liver effects in certain populations 4
- Naltrexone has been safely used in patients with acute viral hepatitis without exacerbating liver disease 5
Precipitated Opioid Withdrawal
One of the most serious risks with naltrexone is precipitated withdrawal:
- Naltrexone can precipitate severe withdrawal in patients who are not completely opioid-free 1
- Symptoms can appear within 5 minutes of ingestion and last up to 48 hours 1
- Withdrawal may be severe enough to require hospitalization 1
- Mental status changes including confusion, somnolence, and visual hallucinations can occur 1
- Significant fluid losses from vomiting and diarrhea may require IV fluid administration 1
To prevent precipitated withdrawal:
- Patients must be opioid-free for at least 7-10 days before starting naltrexone 6, 1
- Patients transitioning from buprenorphine or methadone may be vulnerable to withdrawal for up to two weeks 1
- Naltrexone should be held for 2-3 days prior to elective surgical procedures if opioids are expected to be used perioperatively 6
- Extended-release naltrexone should be held for 24-30 days before elective procedures requiring opioids 6
Common Adverse Effects
In clinical trials and usage studies, the following adverse effects were commonly reported:
- Gastrointestinal: nausea (9.8%), vomiting, abdominal pain/cramps, diarrhea 1, 7
- Neurological: headache (6.6%), dizziness (4%), somnolence (2%) 1, 7
- Psychiatric: nervousness (4%), anxiety (2%), insomnia (3%), fatigue (4%) 1, 7
- Musculoskeletal: joint and muscle pain 1
In a large multicenter usage study, 15% of patients discontinued naltrexone due to adverse events, most frequently nausea 7.
Psychiatric Concerns
Naltrexone has been associated with psychiatric symptoms that require monitoring:
- Depression, suicidal ideation, and suicide attempts have been reported 1
- Depression rates range from 0-15% with naltrexone (compared to 0-17% with placebo) 1
- Suicide attempt/ideation rates range from 0-1% with naltrexone (compared to 0-3% with placebo) 1
- Patients and families should be alerted to monitor for emergence of depression or suicidality 1
Special Considerations
- Liver disease: Cautious use is recommended in patients with hepatic impairment 6
- Surgery: Hold oral naltrexone for 2-3 days prior to elective procedures if opioids are expected 6
- Pain management: Patients on naltrexone may have difficulty achieving adequate analgesia with opioids 6
- Constipation management: Naltrexone may be useful in combination with opioids to limit constipation, particularly in vulnerable populations like Parkinson's disease and elderly patients 6
Monitoring Recommendations
- Monitor liver function tests before and periodically during treatment 1
- Watch for signs of hepatitis (jaundice, abdominal pain, elevated transaminases) 1
- Screen for depression and suicidal ideation regularly 1
- Ensure patients are completely opioid-free before initiating treatment 1
By understanding these potential issues with naltrexone use, clinicians can appropriately select patients for treatment, monitor for adverse effects, and manage complications when they arise.